Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer

Umberto Capitanio, Sasha Ahyai, Markus Graefen, Claudio Jeldres, Shahrokh F. Shariat, Andreas Erbersdobler, Thorsten Schlomm, Alexander Haese, Thomas Steuber, Hans Heinzer, Paul Perrotte, François Péloquin, Daniel Pharand, Philippe Arjane, Hartwig Huland, Pierre I. Karakiewicz

Research output: Contribution to journalArticle

Abstract

Objectives: To examine the rate of biochemical recurrence (BCR) in patients with pathologically confirmed insignificant prostate cancer (PIPCa). Methods: A total of 1358 patients underwent open retropubic radical prostatectomy at the University Medical Center Eppendorf in Hamburg, Germany, and their specimens were whole-mounted, step-sectioned, and subjected to computer-based three-dimensional reconstruction. We identified patients who fulfilled the Epstein criteria for definition of PIPCa (tumor volume ≤0.5 mL, Gleason score ≤6, organ-confined disease) and we compared the BCR-free rates between the PIPCa and non-PIPCa groups. Results: Pathologically confirmed insignificant prostate cancer was found in 69 patients (5%). At 1, 2, 5, and 10 years, the BCR-free rate for PIPCa patients was 100% vs, respectively, 97%, 91%, 74%, and 38% for other patients (log-rank P

Original languageEnglish
Pages (from-to)1208-1211
Number of pages4
JournalUrology
Volume72
Issue number6
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Prostatic Neoplasms
Recurrence
Neoplasm Grading
Prostatectomy
Tumor Burden
Germany

ASJC Scopus subject areas

  • Urology

Cite this

Capitanio, U., Ahyai, S., Graefen, M., Jeldres, C., Shariat, S. F., Erbersdobler, A., ... Karakiewicz, P. I. (2008). Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer. Urology, 72(6), 1208-1211. https://doi.org/10.1016/j.urology.2008.04.053

Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer. / Capitanio, Umberto; Ahyai, Sasha; Graefen, Markus; Jeldres, Claudio; Shariat, Shahrokh F.; Erbersdobler, Andreas; Schlomm, Thorsten; Haese, Alexander; Steuber, Thomas; Heinzer, Hans; Perrotte, Paul; Péloquin, François; Pharand, Daniel; Arjane, Philippe; Huland, Hartwig; Karakiewicz, Pierre I.

In: Urology, Vol. 72, No. 6, 12.2008, p. 1208-1211.

Research output: Contribution to journalArticle

Capitanio, U, Ahyai, S, Graefen, M, Jeldres, C, Shariat, SF, Erbersdobler, A, Schlomm, T, Haese, A, Steuber, T, Heinzer, H, Perrotte, P, Péloquin, F, Pharand, D, Arjane, P, Huland, H & Karakiewicz, PI 2008, 'Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer', Urology, vol. 72, no. 6, pp. 1208-1211. https://doi.org/10.1016/j.urology.2008.04.053
Capitanio, Umberto ; Ahyai, Sasha ; Graefen, Markus ; Jeldres, Claudio ; Shariat, Shahrokh F. ; Erbersdobler, Andreas ; Schlomm, Thorsten ; Haese, Alexander ; Steuber, Thomas ; Heinzer, Hans ; Perrotte, Paul ; Péloquin, François ; Pharand, Daniel ; Arjane, Philippe ; Huland, Hartwig ; Karakiewicz, Pierre I. / Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer. In: Urology. 2008 ; Vol. 72, No. 6. pp. 1208-1211.
@article{75867f6f7267435985ab782fffb42505,
title = "Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer",
abstract = "Objectives: To examine the rate of biochemical recurrence (BCR) in patients with pathologically confirmed insignificant prostate cancer (PIPCa). Methods: A total of 1358 patients underwent open retropubic radical prostatectomy at the University Medical Center Eppendorf in Hamburg, Germany, and their specimens were whole-mounted, step-sectioned, and subjected to computer-based three-dimensional reconstruction. We identified patients who fulfilled the Epstein criteria for definition of PIPCa (tumor volume ≤0.5 mL, Gleason score ≤6, organ-confined disease) and we compared the BCR-free rates between the PIPCa and non-PIPCa groups. Results: Pathologically confirmed insignificant prostate cancer was found in 69 patients (5{\%}). At 1, 2, 5, and 10 years, the BCR-free rate for PIPCa patients was 100{\%} vs, respectively, 97{\%}, 91{\%}, 74{\%}, and 38{\%} for other patients (log-rank P",
author = "Umberto Capitanio and Sasha Ahyai and Markus Graefen and Claudio Jeldres and Shariat, {Shahrokh F.} and Andreas Erbersdobler and Thorsten Schlomm and Alexander Haese and Thomas Steuber and Hans Heinzer and Paul Perrotte and Fran{\cc}ois P{\'e}loquin and Daniel Pharand and Philippe Arjane and Hartwig Huland and Karakiewicz, {Pierre I.}",
year = "2008",
month = "12",
doi = "10.1016/j.urology.2008.04.053",
language = "English",
volume = "72",
pages = "1208--1211",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer

AU - Capitanio, Umberto

AU - Ahyai, Sasha

AU - Graefen, Markus

AU - Jeldres, Claudio

AU - Shariat, Shahrokh F.

AU - Erbersdobler, Andreas

AU - Schlomm, Thorsten

AU - Haese, Alexander

AU - Steuber, Thomas

AU - Heinzer, Hans

AU - Perrotte, Paul

AU - Péloquin, François

AU - Pharand, Daniel

AU - Arjane, Philippe

AU - Huland, Hartwig

AU - Karakiewicz, Pierre I.

PY - 2008/12

Y1 - 2008/12

N2 - Objectives: To examine the rate of biochemical recurrence (BCR) in patients with pathologically confirmed insignificant prostate cancer (PIPCa). Methods: A total of 1358 patients underwent open retropubic radical prostatectomy at the University Medical Center Eppendorf in Hamburg, Germany, and their specimens were whole-mounted, step-sectioned, and subjected to computer-based three-dimensional reconstruction. We identified patients who fulfilled the Epstein criteria for definition of PIPCa (tumor volume ≤0.5 mL, Gleason score ≤6, organ-confined disease) and we compared the BCR-free rates between the PIPCa and non-PIPCa groups. Results: Pathologically confirmed insignificant prostate cancer was found in 69 patients (5%). At 1, 2, 5, and 10 years, the BCR-free rate for PIPCa patients was 100% vs, respectively, 97%, 91%, 74%, and 38% for other patients (log-rank P

AB - Objectives: To examine the rate of biochemical recurrence (BCR) in patients with pathologically confirmed insignificant prostate cancer (PIPCa). Methods: A total of 1358 patients underwent open retropubic radical prostatectomy at the University Medical Center Eppendorf in Hamburg, Germany, and their specimens were whole-mounted, step-sectioned, and subjected to computer-based three-dimensional reconstruction. We identified patients who fulfilled the Epstein criteria for definition of PIPCa (tumor volume ≤0.5 mL, Gleason score ≤6, organ-confined disease) and we compared the BCR-free rates between the PIPCa and non-PIPCa groups. Results: Pathologically confirmed insignificant prostate cancer was found in 69 patients (5%). At 1, 2, 5, and 10 years, the BCR-free rate for PIPCa patients was 100% vs, respectively, 97%, 91%, 74%, and 38% for other patients (log-rank P

UR - http://www.scopus.com/inward/record.url?scp=56449106307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449106307&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2008.04.053

DO - 10.1016/j.urology.2008.04.053

M3 - Article

C2 - 18692880

AN - SCOPUS:56449106307

VL - 72

SP - 1208

EP - 1211

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -